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Tyrosinase activity is a key determinant of melanin produc-
tion in skin. Because retinoic acid regulates tyrosinase activity 
in melanoma cells, we analyzed modulation of pigmentation 
in vivo by retinoic acid. Black and white subjects were either 
not treated, or treated topically for 4 d under occlusion with 
vehicle, retinoic acid (0.1 %), or the irritant sodium lauryl 
sulfate (2%). In untreated skin, tyrosinase activity and mela-
nin content were significantly greater (2.3 times, and 3.2 
times, respectively) in blacks versus whites. Four days of 
treatment with topical retinoic acid did not alter tyrosinase 
activity or melanin content in black skin. In contrast, retinoic 
acid treatment significantly induced (2.7 times, n = 8) tyro-
sinase activity, compared to vehicle treatment, in white skin. 
Melanin content, however, remained unchanged at 4 d. In 
separate experiments, tyrosinase activity in white subjects 
(n = 25) was increased 16% (p = 0.01) in sodium lauryl 
sulfate - treated skin, and 77% (p = 0.0005) in retinoic acid-
treated skin, compared to vehicle-treated skin. The effect of 
T yrosinase is the rate-limiting enzyme in the biosynthe-sis of the skin pigment melanin [1-4]. Tyrosinase catalyses three different reactions in the biosynthetic pathway of melanin: 1) the hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine (DOPA); 2)oxidation 
of DOPA to DOPA-quinone; and 3) the oxidation of 5,6-dihy-
droxyindole (DHI) to indole-quinone [1]. The rate-limiting steps in 
melanogenesis occur at the level of the oxidations of tyrosine and 
dopa, and the quantity of melanin synthesized is proportional to the 
amount of tyrosinase activity present in the cell [5]. Furthermore, in 
humans, evidence indicates that human skin color can be correlated 
with tyrosinase activity [6,7] . 
Tyrosinase has been purified from mouse and human melanoma 
cell lines and has been shown to be highly homologous in the two 
species [8,9] . The cDNA sequences of mouse and human tyrosinase 
display 80% sequence identity [10,11]. In mouse melanoma cells 
tyrosinase has been shown to exist in a number of discrete forms 
ranging in molecular weight from 58,000 to 150,000 [12]. The 
molecular heterogeneity of tyrosinase is thought to arise through 
Manuscript received August 11, 1992; accepted for publication February 
3, 1993. 
Reprint requests to: Gary J. Fisher, Department of Dermatology, Kresge I, 
R6558, University of Michigan, Ann Arbor, Michigan 48109. 
Abbreviations: DHI, 5,6-dihydroxyindole; RA, retinQic acid; SLS, sodium 
lauryl sulfate. 
retinoic acid on tyrosinase activity could be differentiated 
from non-specific irritation, because tyrosinase activity in 
retinoic acid - treated skin was significantly greater (52%, 
p = 0.004) than sodium lauryl sulfate-treated skin. Similar 
results were obtained with the dihydroxyphenylalanine reac-
tion done on vehicle, sodium lauryl sulfate -, and retinoic 
acid-treated white skin. Northern analysis (n = 6) and 
semi-quantitative polymerase chain reaction (n = 6) demon-
strated that retinoic acid treatment did not alter tyrosinase 
mRNA levels in white skin. Western analysis revealed that 
induction of tyrosinase activity by retinoic acid also was not 
associated with increased tyrosinase protein content (n = 9), 
indicating that regulation of tyrosinase activity by retinoic 
acid occurs through a post-translational mechanism. These 
data demonstrate that low tyrosinase activity in white skin in 
vivo is retinoic acid inducible and high tyrosinase activity in 
black skin in vivo is neither further induced nor reduced by 
retinoic acid.] Invest Dermato[100:800-805, 1993 
post-translational processing including glycosylation of enzyme 
113]. 
Tyrosinase activity is modulated both positively and negatively 
by retinoic acid in mouse as well as human melanoma cells [14-16] . 
We have recently reported that retinoic acid treatment for 6 d does 
not alter either tyrosinase activity or melanin content in normal 
cultured melanocytes from white skin [17]. The objectives of the 
present study were to examine the effect of short-term topical reti-
noic acid treatment on tyrosinase activity and melanin content in 
normal non sun-exposed skin of black and white humans. 
MATERIALS AND METHODS 
Materials L-tyrosine, dihydroxyphenylalanine (L-DOPA), Tri-
ton X-100, and citric acid were purchased from Sigma Chemical 
Co. (St. Louis, MO). Charcoal (Norit A-activated charcoal) was 
obtained from Aldrich Co. Tyrosine ([ ring-3,5-3H ]tyrosine, 50 Cij 
mmolc) and (125I]-goat anti-rabbit IgG (9.8 mCi/mg) were pur-
chased from Dupont New England Nuclear (Boston, MA). Pansor-
bin (Staphylococcus aureus cells) was purchased from Calbiochem (La 
Jolla, CA). Human tyrosinase cDNA (Pmel34) was a generous gift 
of Dr. B. S. Kwon, Indiana University, Indiana. Polyclonal anti-
tyrosinase antibody was a generous gift of Dr. H. Rorsman, Univer-
sity of Lund, Sweden. All other chemicals were of analytical reagent 
grade. 
Treatment of Subjects and Procurement of Tissue For stud-
ies to determine the effects of retinoic acid and sodium lauryl sulfate 
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(SLS) on tyrosinase activity and melanin content, adult white and 
black volunteers were treated topically with 0.1 % all-trans retinoic 
acid (Retin-A cream), vehicle control (Retin-A vehicle), and the 
irritant SLS (2% in the retinoic acid vehicle) on the lower hips or 
buttocks. After application, the areas were covered with plastic 
wrap, held in place with dermatape, to prevent loss of cream and 
enhance penetration. Treated areas were biopsied, by keratome, 96 
h following treatment. For DOPA reaction, 4-mm punch biopsies 
were also obtained from skin treated as described above. For studies 
co compare tyrosinase activity and melanin content in black and 
white skin, keratome biopsies were obtained from black and white 
volunteers who received no topical treatment. Tissue was snap fro-
zen in liquid nitrogen and stored at -70 ° C until used. All proce-
dures involving human subjects were approved by University of 
Michigan Institutional Review Board. 
Preparation of Soluble Tyrosinase Keratome biopsies from 
treated and untreated skin (approximately SO mg wet weight) were 
pulverized by mortar and pestle under liquid nitrogen. The pow-
dered tissue was transferred to a glass homogenizer containing 1 ml 
of sodium phosphate buffer (0.1 M, pH 6.8) with 1% Triton X-IOO 
and homogenized with 15 strokes. The homogenate was then soni-
cated three times (5-second bursts with 30-second rests) with a 
micro tip sonicator. The homogenate was left on ice for 1 h prior to 
centrifugation at 100,000 Xg for 40 min, and the supernatant 
served as the source of tyrosinase activity [7] . 
Tyrosine Hydroxylase Assay The radiometric determination 
of tyrosinase activi ty was performed as previously described [15,18] . 
Briefly, 0.5 ml of a reaction mixture consisting of 0.2 ml skin 
supernatant, 0.1 mM tyrosine, 0.1 mM L-DOPA, and 2 flCi of 
pH]tyrosine in phosphate buffer was incubated at 37°C for 2 h. 
This assay measures the production of pH ]H20 during the conver-
sion of [3H]tyrosine to L-DOPA. The reaction was terminated by 
addition of 500 ,ul of 10% trichloroacetic acid and centrifuged at 
2,000 X g for 5 min. Supernatants were transferred to tubes con-
taining 1 ml charcoal (10% w /v in 0.1 M citric acid) and centrifuged 
ac 2,000 X g for 10 min. The resultant supernatants (0.3 m1) were 
counted by liquid-scintillation spectrometry. 
Melanin Assay To determine melanin content skin biopsies (50 
mg) -were homogenized in 1 ml phosphate buffer as described 
above, and the melanin in 0.35 ml of the resulting homogenate 
solubilized by treatment with 2 N NaOH at 60°C for 4 d. An equal 
volume of water was then added followed by the addition of 0.7 ml 
of chloroform: phenol (1 : 1). The mixture was vortexed and centri-
fuged at 5000 X g for 10 min to separate the phases. Melanin con-
tent in the water layer was determined spectrophotometrically at 
400 nm [7,19J. Values are expressed as micrograms of melanin per 
milligram wet weight of skin. 
RNA Blot Hybridization Total RNA was prepared from kera-
tome biopsies of vehicle- and retinoic acid-treated skin by cesium 
chloride density centrifugation [20], and size fractionated on a 1.2% 
formaldehyde denaturing agarose gel. The RNA was transferred to 
nylon membranes and hybridized to (32P]labeled human tyrosinase 
(pmel34) and rat cyclophilin cDNA probes [20J. The filters were 
subsequently washed two times for 30 min each in 2 X sodium 
citrate/sodium chloride buffer (SSe) plus 0.1 % sodium dodecylsul-
fate (SDS) at 42°C, and one time with 0.2 X ssc plus 0.1 % SDS at 
65°C for 1 h. The transcript for cyclophilin was used as an internal 
control, because its level does not vary with retinoic acid treatment 
[21 J. 
Semi-Quantitative PCR Reverse transcriptase/polymerase 
chain reaction was performed under conditions that allowed the 
relative levels of tyrosinase mRNA in vehicle- and retinoic acid-
treated skin to be determined [22] . Rabbit globin mRNA (1.2 pg) 
md total RNA from vehicle- and retinoic acid-treated keratome 
biopsies (1 mg) were combined and reverse transcribed using ran-
dom heximer primers (25 pmol) and 200 U M-ML V H- reverse 
transcriptase, at 37°C for 30 min in 50 mM Tris (pH 8.3), 0.3 mM 
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MgCI2 ' 20 mM dithiothreitol, 500 mM dXTP, and 20 units RNAse 
inhibitor. Following this, three fourfold dilutions of the reverse-
transcriptase reaction were made. To each dilution, specific human 
tyrosinase and rabbit p-globin primers (50 pmol), and TAQ DNA 
polymerase (2 U) were added, and polymerase chain reaction was 
carried out in 40 mM Tris (pH 8.3), 1.5 mM MgCI2, 125 mM 
dXTP (final concentrations) for 20 cycles at 95 °C for 30 seconds, 
56 ° C for 30 seconds, and 72°C for 30 seconds, with a 3-second 
extension per cycle. Polymerase chain reaction products were sepa-
rated by agarose gel electrophoresis, transferred to nylon mem-
brane, and simultaneously hybridized with [32P]labeled tyrosinase 
and p-globin probes (isolated polymerase chain reaction products). 
Radioactivity in the hybridized bands was quantified by a Phos-
phorlmager (Molecular Dynamics). Results were analyzed as the 
ratio of counts in the tyrosinase band to counts in the p-globin band. 
Over the concentration range of human skin and rabbit globin RNA 
utilized, the amount of polymerase chain reaction products formed 
after 20 cycles was linearly proportional to the amount of RNA 
added. 
Immunoblotting To determine tyrosinase protein content, 
equal amounts of supernatant protein (50 ,ug) prepared from vehi-
cle-, SLS-, and retinoic acid-treated skin as described above were 
separated by SDS-polyacrylamide gel electrophoresis (PAGE) and 
transferred to nitrocellulose membranes. Following transfer, mem-
brane~ ~ere incubated for 3 h in phosphate-buffered saline (PBS) 
contammg 5% non-fat dry milk, 0.02% Tween-20 to block non-
specific binding. The membranes were then incubated with anti-
tyrosinase antibody [23] (1: 250 dilution) overnight at 4°C and 
washed five times in Tween-20/PBS. The membranes were incu-
bated with [125I]goat anti-rabbit IgG in Tween-20/PBS for 2 h at 
room temperature and washed five times with Tween-20/PBS. The 
bands on the membrane were detected by autoradiography and the 
radioactivity in the bands measured by PhosphorImager. 
Immunoprecipitation of Tyrosinase Supernatants from kera-
tome biopsies, prepared as described above, were incubated with 
tyrosinase antisera (1: 200 dilution) for 60 min at 37°C. The im-
munocomplex was precipitated by addition of pansorbin (20,u1) for 
another 30 min followed by centrifugation at 1000 X g for 4 min. 
The precipitate was dissolved in SDS-PAGE sample buffer [24], 
loaded on SDS-PAGE, and immunobloted using the same tyrosin-
ase antisera used for immunoprecipitation. 
DOPA Reaction Four-millimeter punch biopsies obtained from 
the treated areas of black and white skin were placed immediately in 
2 N sodium bromide for 90-120 min at room temperature to sepa-
rate epidermis from dermis. The epidermis was then incubated for 7 
hat 37"C in phosphate buffer (pH 7.4) containing 0.1% DOPA 
[25]. After removal from the DOPA solution, the tissue was rinsed 
with distilled water for 5 min and mounted on a triple-welled slide 
with stratum corneum upwards. The epidermis was examined ml-
croscoplCally and the number of DOPA-positive melanocytes/umt 
area determined. 
Statistical Analysis Differences in group means among treat-
ment groups were analyzed by paired t test. Correlation between 
Northern analysis and semi-quantitative PCR was analyzed by 
Pearson's correlation method. 
RESULTS 
Tyrosinase Activity and Melanin Content in Retinoic Acid-
Treated Black and White Skin To investigate the effects of 
treatment with topical retinoic acid (0 .1%) on melanogenesis in 
adult human skin, ten black and eight white volunteers were treated 
topically with vehicle and retinoic acid (0.1 %) for 4 d and kerato~e 
biopsies obtained from these individuals were analyzed for tyrosm-
ase activity and melanin content. The results in Fig 1 indicate that 
tyrosinase activity and melanin content were unchanged by retinoic 
acid treatment in black skin. In contrast, retinoic acid treatment of 
white skin induced tyrosinase activity nearly threefold (p = 0.01). 
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Figure 1. Tyrosinase activity and melanin content in black and white skin 
treated with retinoic acid. Black and white subjects were treated topically 
under occlusion with retinoic acid (0.1 %) (solid bars) and retinoic acid vehi-
cle (open bars) for 4 d. Tyrosinase activity and melanin content were mea-
sured in keratome biopsies as described in Materials alld Methods. Bars, 
means ± SEM. Tyrosinase activity: retinoic acid versus vehicle in black skin, 
p = 0.14; in white skin, p < 0.01. 
However, 4 d of retinoic acid treatment was not sufficient to pro-
duce a similar increase in melanin content (Fig 1). 
Tyrosinase Activity and Melani~ Conten~ in BI~c~ and 
White Skin In the above study (Fig 1), tyroslllase actiVity and 
melanin content were found to be greater in vehicle-treated skin of 
blacks compared to whites. We therefore examined whether these 
differences were present in untreated black and white skin. Tyro-
sinase activ.ity and melanin content were measured in supernatants 
prepared from kerat~me .biopsies from ten black and. ten whi~e .ind5-
viduals. The results III Fig 2 demonstrate that tyroslllase actiVity III 
black epidermis is significantly greater (2 .3 times, p < 0.0001) than 
in white epidermis. Melanin content was also found to be greater 
(3 .2 times, p < 0.0001) in black skin compared to white skin. 
Comparison of Treatment with Retinoic Acid Versus SLS on 
Tyrosinase Activity in White Skin Topical retinoic acid results 
in an etythmetous "irritant" reaction clinically and histologically 
similar to that observed with topical SLS treatment [26]. We there-
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Figure 2. Comparison of tyrosinase .activity and melanin content in un-
treated normal skin of blacks and whItes. Bars, means ± SEM. Tyrosmase 
activity: black versus white, p < 0.0001. Melanin content: black versus 
white, p < 0.0001. 
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Figure 3. Tyrosinase activity and DOPA stain ing in white skin treated 
with vehicle, SLS, and retinoic acid. Subjects were treated with vehicle 
(VEH) , 5L5, and retinoic acid (RA) for 4 d under occlusion. Tyrosinase 
activity and DOPA staining were measured in keratome biopsies and punch 
biopsies, respectively, as described in Materials alld Methods. Bars, means ± 
SEM. Tyrosinase activity: VEH versus SLS, p = 0.01; VEH versus RA, p = 
0.0002; SLS versus RA, p = 0.004. DOPA staining: VEH versus SLS, p = 
0.01; VEH versus RA, p = 0.0005; SLS versus RA, p = 0.03. 
fore compared the effects of topical treatment with retinoic acid and 
SLS on tyrosinase activity in white skin. In this study white individu-
als were treated with vehicle, SLS (2%), and retinoic acid (0.1 %) for 
4 d under occlusion. Keratome biopsies obtained after treatment 
were analyzed for tyrosinase activity by enzymatic and histochemi-
cal assays. We have previously demonstrated that treatment of skin 
with 2% SLS causes clinical and histologic changes similar to those 
observed with retinoic acid [26]. The results in Fig 3 demonstrate 
that tyrosinase activity was increased 16% (p = 0.01, n = 25), com-
pared to vehicle, with SLS treatment. Retinoic acid treatment re-
sulted in a 77% increase in tyrosinase activity (p = 0.0002, n = 25), 
compared to vehicle, and a 52% increase (p = 0.004, n = 25), com-
pared to SLS. These data suggest that increased tyrosinase activity 
following retinoic acid treatment is not solely due to non-specific 
irritation, because tyrosinase activity is significantly greater follow-
ing retinoic acid treatment than that observed following SLS treat-
ment. Because SLS treatment resulted in a small increase in tyrosin-
ase activity, a small fraction of the observed increase in tyrosinase 
activity following retinoic acid treatment may be attributable to 
irritation. Whether increased tyrosinase activity following retinoic 
acid and SLS treatment occurs through common or distinct mecha-
nisms remains to be determined. 
Tyrosinase activity (DOPA oxidase) was also assessed histochemi-
cally (DOPA stain) in epidermis obtained from vehicle-, SLS-, and 
retinoic acid - treated white individuals. The results in Fig 3 demon-
strate that retinoic acid treatment significantly increased the num-
ber of DOPA-staining melanocytes compared to either vehicle 
(100%, p = 0.0005) or SLS treatment (36%, p = 0.03). Similar to 
what we observed with tyrosinase activity measured biochemically, 
SLS treatment resulted in increased numbers of DOPA-positive 
melanocytes (46%, p = 0.01), compared to vehicle. 
Tyrosinase mRNA Levels in White Skin To determine if the 
observed increase in tyrosinase activity following retinoic acid 
treatment of white skin was associated with increased tyrosinase 
gene expression, steady-state tyrosinase mRN A levels in vehicle and 
retinoic acid-treated white skin were analyzed by Northern blot-
ting and semi-quantitative PCR. The results in Fig 4A,B demon-
strate that retinoic acid treatment did not alter tyrosinase mRNA 
levels in six individuals. There was a significant correlation (r = 
0.93) in the difference of relative tyrosinase mRNA levels between 
retinoic acid- and vehicle-treated skin as measured by Northern 
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Figure 4. Tyrosinase mRNA levels in white skin treated with vehicle and 
retinoic acid. (A) Total RNA was prepared from six white subjects treated 
topically with 0.1 % retinoic acid (RA) and vehicle (VEH) for 4 d. RNA blots 
(top) (30 ,ug/lane) were probed with [32PJlabcled cDNA for human tyrosin-
ase and rat cyc10philin (used as an internal control). Radioactivity in the 
hybridized bands (bottom) were quantified using a PhosphorImager. (B) 
Tyrosinase mRNA levels in thc same RNA samples as in A were determined 
by semi-quantitative peR as described in Materials alld Melhods. Bands were 
quantified by a PhosphorImager. 
analysis and semi-quantitative peR. These results indicate that in-
duction of tyrosinase activity in retinoic acid - treated human skin ill 
vivo may not involve increased tyrosinase gene expression. 
Tyrosinase Protein Levels in White Skin Treated with Reti-
noic Acid We next examined whether tyrosinase protein was 
elevated following 4-d retinoic acid and SLS treatment. Equal 
amounts of protein extracts from vehicle, SLS, and retinoic acid -
treated white skin were immunoblotted with anti-tyrosinase anti-
sera and detected with (125IJgoat anti-rabbit IgG antibody. Three 
prominent bands were observed with molecular weight of 66 kDa 
(the expected molecular weight of tyrosinase), 58 kDa, and 48 kDa. 
No change in intensity of the 66-kDa band was observed following 
retinoic acid and SLS treatment compared to vehicle (Fig SA). 
To further verify the above immunoblot results, solubilized su-
pernatants from retinoic acid and vehicle - treated skin were also 
immunoprecipitated with anti-tyrosinase antibody and the result-
ing immune precipitates and supernatants immunoblotted. Western 
analysis of these immunoprecipitates revealed a single band of the 
expected molecular weight of tyrosinase (66 kDa), which was simi-
lar in intensity in samples from retinoic acid - and vehicle-treated 
skin (Fig SB) . This band was absent in the supernatants from the 
immunoprecipitate, which contained the 58-kDa and 48-kDa 
bands. These data indicate that the observed increase in tyrosinase 
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activity in SLS- and retinoic acid - treated skin was not accompanied 
by a concomitant increase in tyrosinase protein. 
DISCUSSION 
The above data demonstrate that tyrosinase activity is induced by 
short-term topical retinoic acid treatment in white, but not in black, 
skin. The molecular basis for this difference is not known. One 
possible explanation for the lack of inducibility of tyrosinase activity 
following retinoic acid treatment in black skin may be related to our 
finding that the level of tyrosinase activity was 2.3-times higher in 
black, compared to white, skin. This difference presumably reflects 
differences in the genetic regulation of tyrosinase activity between 
black and white skin, which may confer refractoriness of tyrosinase 
in black skin to further induction by topical retinoic acid. The lack 
of inducibility of tyrosinase activity in black skin is not necessarily a 
general phenomen, but rather restricted to retinoic acid (and per-
haps other) treatment, because black skin undergoes a delayed tan-
ning reaction. Data indicates that delayed tanning is associated with 
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Figure 5. Immunoblot analysis of ryrosinase protein in white skin treated 
with vehicle, SLS, and retinoic acid. (A) Supernatants from detergent solu-
bilized keratome biopsies from four subjects treated WIth veluclc (VEH) , 
SLS, and retinoic acid (RA), and from three individuals rreated WIth velllcle 
and retinoic acid were immunoblotted with anti-tyrosinase antibody as de-
scribed in Materials alld Methods (lOp) . Radioactiviry in the tyrosinase band 
(66 kDa) was quantified by a PhosphorImager (bottom). Bars, means ± SEM. 
(B) lmmunoprecipitation of tyrosinase protein. Supernacancs f~om deter-
gent solubilized keratome biopsies from vehicle- and retmOlc aCid - treated 
skin were iml11unoprecipitaccd with anti-ryrosinase antibody. The. superna-
tants (Iaues 1 and 2) and immune precipitates (Ialles 3 and 4) were Immuno-
blotted with the immunoprecipitating antibody. Lallcs 1 and 3, velllcle-
treated skin; iar!eS 2 and 4, retinoic acid - treated skin. Results arc 
representative of three experiments. 
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increased tyrosinase activity [27]. Our data demonstrating increased 
tyrosinase activity and melanin content in adult black skin is consist-
ent with reported differences in tyrosinase activity and melamn 
content in black and white neonatal foreskins [7]. 
Induction of tyrosinase activity in white skin treated with topical 
retinoic acid was not accompanied by increases in either tyrosinase 
mRNA or protein. These data suggest that modulation of tyrosinase 
activity following retinoic acid treatment occurs through post-tran-
scriptional mechanisms. Induction of tyrosinase activity by a-MSH 
has been reported to occur through suppression of an inhibitor 
[28,29]. A similar mechanism could be operating in response to 
retinoic acid. Alternatively, elevation of tyrosinase activity by reti-
noic acid may involve induction of an activating factor or direct 
modification, for example, through phosphorylation or glycosyla-
tion, of pre-existing tyrosinase molecules [30). Increased tyrosinase 
activity in black versus white foreskins was found to be due to a 
higher kinetic velocity (V max), rather than higher levels of tyrosin-
ase protein [7). These data provide additional evidence for the role 
of post-transcriptional mechanisms in the regulation of tyrosinase 
activity. The molecular mechanism(s) through which retinoic acid 
treatment leads to increased tyrosinase activity remains to be deter-
mined. We have previously reported that retinoic acid treatment 
does not alter tyrosinase <tctivity or melanin content in normal 
human melanocytes cultured from white skin [17). These data sug-
gest that modulation of tyrosinase activity in retinoic acid-treated 
skin may involve multiple complex secondary and tertiary interac-
tions that are not directly amenable to study in simple ill vitro cell 
culture models. 
It is of interest that retinoic acid neither induced or suppressed 
tyrosinase activity in black skin. Retinoic acid has been reported to 
both increase and decrease tyrosinase activity in human and mouse 
melanoma cells [16,31-35). In Cloudman S91 melanoma cells, 
retinoic acid inhibits induction of tyrosinase activity by a-melano-
cyte-stimulating hormone, although retinoic acid by itself has no 
effect [33]. In a human melanoma cell line retinoic acid induces 
tyrosinase a~tivity, following a 4-d lag period [16). In both mela-
noma cell lines basal tyrosinase activity is relatively low. Based on 
these ill vitro results one would predict that retinoic acid might 
potentiate relatively low tyrosinase activity in white skin and reduce 
high tyrosinase activity in black skin. The fact that black skin was 
unaffected suggests that increased tyrosinase activity may not be 
hormonally mediated. 
Although retinoic acid induced tyrosinase activity in white skin, 
this did not lead to increased melanin content. This may have been 
due to the short 4-d course of treatment, which may not have been 
enough time for detectable accumulation of melanin to occur. It 
should be pointed out, however, that increased melanin content 
following exposure to ultraviolet radiation occurs with 2- 3 d . In 
addition, although tyrosinase is generally believed to be rate limit-
ing for melanin synthesis, melanization is a complex process involv-
ing many factors, such as substrate availability and post-tyrosinase 
regulatory proteins [4,36-38], that directly participate in melanin 
synthesis, and is dependent on melanosome maturation, intra-me-
lanocyte melanosome transport, and transfer of melanosomes to 
keratinocytes. The regulation of each of these components may 
influence melanin synthesis ill vivo. 
We have recently demonstrated that topical retinoic acid (0.1 %) 
treatment significantly reduced hyperpigmented lesions (liver 
spots) associated with photodamage in w~ite patients [39). In nor-
mal white skin, however, we observed l11creased, not decreased, 
tyrosinase activity following retinoic acid treatment. Thus, retinoic 
acid treatment may be capable of modulating tyrosinase activity ill 
vivo both positively and negatively depending on the degree of 
pigmentation and the state of the skin being treated. This suggests 
that mechanisms involved in cutaneous responses to retinoic acid 
treatment are complex. 
In summary, our data demonstrate that low tyrosinase activity in 
white skin is induced by retinoic acid ill vivo, whereas high tyrosin-
ase in black skin is neither further induced or reduced. The finding 
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of high tyrosinase activity and melanin content in black skin, and 
the inducibility of tyrosinase activity by retinoic acid in white skin, 
raise the possibility that long-term retinoic acid treatment might 
produce increased melanin content in white skin. A study address-
ing this is presently in progress. 
This work was supported in part by the R. W. jOlltlSOIl Pharmaceutical Rescorcll 
blStitllte alld the Babcock Dermatological Flmd. 
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